Search

Pamela Rodriguez

Examiner (ID: 16616, Phone: (571)272-7122 , Office: P/3657 )

Most Active Art Unit
3657
Art Unit(s)
3613, 3683, 3642, 3657, 3103, 3616
Total Applications
1957
Issued Applications
1629
Pending Applications
123
Abandoned Applications
230

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5967295 [patent_doc_number] => 20020090343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-07-11 [patent_title] => 'Expanded perborate salt, use, and method of production' [patent_app_type] => new [patent_app_number] => 09/932766 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5477 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0090/20020090343.pdf [firstpage_image] =>[orig_patent_app_number] => 09932766 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/932766
Expanded perborate salt, use, and method of production Aug 16, 2001 Issued
Array ( [id] => 1413726 [patent_doc_number] => 06514518 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-04 [patent_title] => 'Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof' [patent_app_type] => B2 [patent_app_number] => 09/932245 [patent_app_country] => US [patent_app_date] => 2001-08-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 8387 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/514/06514518.pdf [firstpage_image] =>[orig_patent_app_number] => 09932245 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/932245
Dosage forms exhibiting multi-phasic release kinetics and methods of manufacture thereof Aug 16, 2001 Issued
Array ( [id] => 6688012 [patent_doc_number] => 20030031737 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'Medicinal composition and method of using it' [patent_app_type] => new [patent_app_number] => 09/923090 [patent_app_country] => US [patent_app_date] => 2001-08-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6294 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031737.pdf [firstpage_image] =>[orig_patent_app_number] => 09923090 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/923090
Medicinal composition and method of using it Aug 5, 2001 Issued
Array ( [id] => 5999356 [patent_doc_number] => 20020028239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-03-07 [patent_title] => 'Tablet composition' [patent_app_type] => new [patent_app_number] => 09/920830 [patent_app_country] => US [patent_app_date] => 2001-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3457 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20020028239.pdf [firstpage_image] =>[orig_patent_app_number] => 09920830 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/920830
Tablet composition Aug 2, 2001 Issued
Array ( [id] => 1406802 [patent_doc_number] => 06524611 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-02-25 [patent_title] => 'Compositions containing creatine and creatinine' [patent_app_type] => B2 [patent_app_number] => 09/917634 [patent_app_country] => US [patent_app_date] => 2001-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9436 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524611.pdf [firstpage_image] =>[orig_patent_app_number] => 09917634 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/917634
Compositions containing creatine and creatinine Jul 30, 2001 Issued
Array ( [id] => 6687983 [patent_doc_number] => 20030031708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-13 [patent_title] => 'SYNERGISTIC FILLER COMPOSITION' [patent_app_type] => new [patent_app_number] => 09/915057 [patent_app_country] => US [patent_app_date] => 2001-07-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 1020 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0031/20030031708.pdf [firstpage_image] =>[orig_patent_app_number] => 09915057 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/915057
Synergistic filler composition Jul 24, 2001 Issued
09/857795 Medicinal compositions for oral use Jul 18, 2001 Abandoned
Array ( [id] => 1316588 [patent_doc_number] => 06605302 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-08-12 [patent_title] => 'Drug delivery device containing oseltamivir and an H1 antagonist' [patent_app_type] => B2 [patent_app_number] => 09/907486 [patent_app_country] => US [patent_app_date] => 2001-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10139 [patent_no_of_claims] => 38 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/605/06605302.pdf [firstpage_image] =>[orig_patent_app_number] => 09907486 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/907486
Drug delivery device containing oseltamivir and an H1 antagonist Jul 16, 2001 Issued
09/856585 CAPSULES CONTAINING ONE OR MORE ANTIGENIC SUBSTANCES FOR PREVENTION AND / OR TREATMENT OF AUTO - IMMUNE DISEASES Jul 16, 2001 Abandoned
Array ( [id] => 1502459 [patent_doc_number] => 06465010 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-10-15 [patent_title] => 'Means for creating a mass having structural integrity' [patent_app_type] => B1 [patent_app_number] => 09/902751 [patent_app_country] => US [patent_app_date] => 2001-07-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 7301 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 109 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/465/06465010.pdf [firstpage_image] =>[orig_patent_app_number] => 09902751 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/902751
Means for creating a mass having structural integrity Jul 11, 2001 Issued
Array ( [id] => 1362360 [patent_doc_number] => 06565880 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-05-20 [patent_title] => 'Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea' [patent_app_type] => B2 [patent_app_number] => 09/902822 [patent_app_country] => US [patent_app_date] => 2001-07-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 7 [patent_no_of_words] => 5480 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/565/06565880.pdf [firstpage_image] =>[orig_patent_app_number] => 09902822 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/902822
Oral dosage formulations of 1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3-4-(2-morpholin-4-yl-ethoxy)-naphthalen-1-yl-urea Jul 10, 2001 Issued
Array ( [id] => 6274905 [patent_doc_number] => 20020106412 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-08-08 [patent_title] => 'Method and materials for controlling migration of binder liquid in a powder' [patent_app_type] => new [patent_app_number] => 09/904190 [patent_app_country] => US [patent_app_date] => 2001-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9550 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 60 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20020106412.pdf [firstpage_image] =>[orig_patent_app_number] => 09904190 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/904190
Method and materials for controlling migration of binder liquid in a powder Jul 9, 2001 Abandoned
Array ( [id] => 6079958 [patent_doc_number] => 20020081333 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-06-27 [patent_title] => 'Orally administrable opioid formulations having extended duration of effect' [patent_app_type] => new [patent_app_number] => 09/891882 [patent_app_country] => US [patent_app_date] => 2001-06-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9354 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0081/20020081333.pdf [firstpage_image] =>[orig_patent_app_number] => 09891882 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/891882
Orally administrable opioid formulations having extended duration of effect Jun 25, 2001 Issued
Array ( [id] => 1513883 [patent_doc_number] => 06419958 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2002-07-16 [patent_title] => 'Extended release formulation of venlafaxine hydrochloride' [patent_app_type] => B2 [patent_app_number] => 09/884412 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4925 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/419/06419958.pdf [firstpage_image] =>[orig_patent_app_number] => 09884412 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/884412
Extended release formulation of venlafaxine hydrochloride Jun 18, 2001 Issued
Array ( [id] => 1195899 [patent_doc_number] => 06726929 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-04-27 [patent_title] => 'Pharmaceutical mixture comprising a profen' [patent_app_type] => B1 [patent_app_number] => 09/868092 [patent_app_country] => US [patent_app_date] => 2001-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4287 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 38 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/726/06726929.pdf [firstpage_image] =>[orig_patent_app_number] => 09868092 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/868092
Pharmaceutical mixture comprising a profen Jun 13, 2001 Issued
Array ( [id] => 1406922 [patent_doc_number] => 06524618 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-02-25 [patent_title] => 'Directly compressible extended-release matrix formulation for metformin hydrochloride' [patent_app_type] => B1 [patent_app_number] => 09/879748 [patent_app_country] => US [patent_app_date] => 2001-06-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3907 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 458 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/524/06524618.pdf [firstpage_image] =>[orig_patent_app_number] => 09879748 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/879748
Directly compressible extended-release matrix formulation for metformin hydrochloride Jun 11, 2001 Issued
Array ( [id] => 7078187 [patent_doc_number] => 20010041165 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-11-15 [patent_title] => 'Effervescent bisphosphonate formulation' [patent_app_type] => new [patent_app_number] => 09/878557 [patent_app_country] => US [patent_app_date] => 2001-06-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2272 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0041/20010041165.pdf [firstpage_image] =>[orig_patent_app_number] => 09878557 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/878557
Effervescent bisphosphonate formulation Jun 10, 2001 Abandoned
Array ( [id] => 1154443 [patent_doc_number] => 06761903 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2004-07-13 [patent_title] => 'Clear oil-containing pharmaceutical compositions containing a therapeutic agent' [patent_app_type] => B2 [patent_app_number] => 09/877541 [patent_app_country] => US [patent_app_date] => 2001-06-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 25354 [patent_no_of_claims] => 122 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 82 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/761/06761903.pdf [firstpage_image] =>[orig_patent_app_number] => 09877541 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/877541
Clear oil-containing pharmaceutical compositions containing a therapeutic agent Jun 7, 2001 Issued
Array ( [id] => 1068423 [patent_doc_number] => 06843983 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2005-01-18 [patent_title] => 'Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae' [patent_app_type] => utility [patent_app_number] => 09/875198 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2159 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/843/06843983.pdf [firstpage_image] =>[orig_patent_app_number] => 09875198 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/875198
Shaving preparations and methods for the prevention and treatment of pseudofolliculitis barbae Jun 6, 2001 Issued
Array ( [id] => 1308318 [patent_doc_number] => 06613358 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2003-09-02 [patent_title] => 'Sustained-release composition including amorphous polymer' [patent_app_type] => B2 [patent_app_number] => 09/877330 [patent_app_country] => US [patent_app_date] => 2001-06-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 42 [patent_no_of_words] => 22843 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 152 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/613/06613358.pdf [firstpage_image] =>[orig_patent_app_number] => 09877330 [rel_patent_id] =>[rel_patent_doc_number] =>)
09/877330
Sustained-release composition including amorphous polymer Jun 6, 2001 Issued
Menu